- Natural
- Porcine
- Bovine
- Avian
- Synthetic
- Polymers
- Oxidized Regenerated Cellulose (ORC)
- Ethylene Diamine Tetraacetic Acid (EDTA)
Collagen Wound Dressing Market size was USD 6.4 billion in 2022 and is poised to grow at a CAGR of 5.3% from 2023-2029. Collagen is derived from animals, usually pigs, cattle, and horses. Collagen supports the effective development of cells in the affected area. Collagen wound dressing is more significant in patients with diabetes than traditional wound dressing. These may be anti-microbial or non-antimicrobial. The global collagen wound dressing market is expected to grow at significant rates over the forecast period owing to the growing number of skin and other injuries around the world. Market players are adopting strategies such as acquisitions and mergers to increase their market share globally. For instance, in July 2013, Concepts Inc. acquired UK-based global leader Systagenix, to strengthen its position in the global advanced wound care market. Furthermore, companies also collaborate with research organizations and institutes to advance wound care treatments including collagen wound dressing. For Instance, in June 2017, AMOEBA announced today the development of a collaboration with VISCUS BIOLOGICS in order to carry out collective testing on a new wound care application in the field of human health.
Collagen Wound Dressing Market Key Development:
- In December 2020, The GUIDOR® Synthetic Bone Graft and Membrane Business of Sunstar has been acquired by Collagen Matrix. Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices and a Linden Capital Partners portfolio company, announced today the acquisition of Sunstar's Degradable Solutions division (the "Company"), which includes the GUIDOR® branded line of resorbable synthetic medical implants.
- In 2019, Collagen Matrix, Inc. Spine business unit has received FDA 510(k) approval for their revolutionary line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix.
Collagen Wound Dressing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.3%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Collagen Wound Dressing Market Dynamics
The market is mainly driven by the increase in the number of diabetes patients worldwide and rise in number of accidents. In addition, rising ageing population and adaptation of advanced wound care dressings for the better treatment of the wounds are expected to boost the market over the forecast period. Furthermore, continuous improvements in dressings such as combination with antibiotics and painkillers coupled with increase in the awareness related to wound care projected to bolster the market growth during the forecast period. However, high prices and dearth of favorable reimbursement policies expected to act as restraints for the market growth.
North-America Got Significant Share of
Collagen Wound Dressing Market Regional Analysis
North America Collagen Wound Dressing Market is expected to have a significant share in global market owing to the increase in the incidence of accidents, injuries and burns. In addition, growing prevalence of diabetes due to the lifestyle are expected to boost the market share in the region. According to the report of American Burn Association 2011, approximately 486000 burn injuries has taken place in the US. Asia Pacific Region projected as a lucrative market for global collagen wound dressing market due to the raising adaptation of advanced wound care treatments, growing awareness related to the wound care coupled with growing prevalence rates of diabetes due to the lifestyle changes. Europe Collagen Wound Dressing Market is expected to grow at notable rates owing to the presence of key market players and adaptation of advanced treatment options.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Collagen Wound Dressing Market Segmentation
By Source
Based On Combination
- Antimicrobial
- Non-Antimicrobial
Based On Forms
- Gels
- Pastes
- Powders
- Others
By Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Hospitals
- Others
Frequently Asked Questions
The CAGR of the collagen wound dressing market is 5.3% over the forecast period (2022 - 2028)
Acelity LP Inc., Coloplast A/S, IonMed, ConvaTec Group Plc, Medtronic plc
The Asia Pacific is the fastest-growing region for the collagen wound dressing market
| 1. Executive Summary |
| 2. Global Collagen Wound Dressing Market Introduction |
| 2.1. Global Collagen Wound Dressing Market - Taxonomy |
| 2.2. Global Collagen Wound Dressing Market - Definitions |
| 2.2.1. By Source |
| 2.2.2. By Combination |
| 2.2.3. By Forms |
| 2.2.4. By Distribution Channel |
| 2.2.5. Region |
| 3. Global Collagen Wound Dressing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Key Developments |
| 4. Global Collagen Wound Dressing Market By Source, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 4.1. Natural |
| 4.1.1. Porcine |
| 4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.1.3. Market Opportunity Analysis |
| 4.1.2. Bovine |
| 4.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.2.3. Market Opportunity Analysis |
| 4.1.3. Avian |
| 4.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.3.3. Market Opportunity Analysis |
| 4.2. Synthetic |
| 4.2.1. Polymers |
| 4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.1.3. Market Opportunity Analysis |
| 4.2.2. Oxidized Regenerated Cellulose (ORC) |
| 4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.2.3. Market Opportunity Analysis |
| 4.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 4.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3.3. Market Opportunity Analysis |
| 5. Global Collagen Wound Dressing Market By Combination, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Antimicrobial |
| 5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Non-Antimicrobial |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Collagen Wound Dressing Market By Forms, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Gels |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pastes |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Powders |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Collagen Wound Dressing Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Retail Pharmacy |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Online Pharmacy |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospitals |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Collagen Wound Dressing Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Collagen Wound Dressing Market - Opportunity Analysis Index, By Combination, Source, Forms, Distribution Channel, , , , and Region, 2023-2029 |
| 9. North America Collagen Wound Dressing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Source Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Natural |
| 9.1.1.1. Porcine |
| 9.1.1.2. Bovine |
| 9.1.1.3. Avian |
| 9.1.2. Synthetic |
| 9.1.2.1. Polymers |
| 9.1.2.2. Oxidized Regenerated Cellulose (ORC) |
| 9.1.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 9.2. Combination Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Antimicrobial |
| 9.2.2. Non-Antimicrobial |
| 9.3. Forms Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Gels |
| 9.3.2. Pastes |
| 9.3.3. Powders |
| 9.3.4. Others |
| 9.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Retail Pharmacy |
| 9.4.2. Online Pharmacy |
| 9.4.3. Hospitals |
| 9.4.4. Others |
| 9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.5.1. USA |
| 9.5.2. Canada |
| 10. Europe Collagen Wound Dressing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Source Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Natural |
| 10.1.1.1. Porcine |
| 10.1.1.2. Bovine |
| 10.1.1.3. Avian |
| 10.1.2. Synthetic |
| 10.1.2.1. Polymers |
| 10.1.2.2. Oxidized Regenerated Cellulose (ORC) |
| 10.1.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 10.2. Combination Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Antimicrobial |
| 10.2.2. Non-Antimicrobial |
| 10.3. Forms Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Gels |
| 10.3.2. Pastes |
| 10.3.3. Powders |
| 10.3.4. Others |
| 10.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Retail Pharmacy |
| 10.4.2. Online Pharmacy |
| 10.4.3. Hospitals |
| 10.4.4. Others |
| 10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1. Germany |
| 10.5.2. France |
| 10.5.3. Italy |
| 10.5.4. Spain |
| 10.5.5. UK |
| 10.5.6. Rest of Europe |
| 11. Asia Pacific Collagen Wound Dressing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Source Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Natural |
| 11.1.1.1. Porcine |
| 11.1.1.2. Bovine |
| 11.1.1.3. Avian |
| 11.1.2. Synthetic |
| 11.1.2.1. Polymers |
| 11.1.2.2. Oxidized Regenerated Cellulose (ORC) |
| 11.1.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 11.2. Combination Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Antimicrobial |
| 11.2.2. Non-Antimicrobial |
| 11.3. Forms Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Gels |
| 11.3.2. Pastes |
| 11.3.3. Powders |
| 11.3.4. Others |
| 11.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Retail Pharmacy |
| 11.4.2. Online Pharmacy |
| 11.4.3. Hospitals |
| 11.4.4. Others |
| 11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1. China |
| 11.5.2. Japan |
| 11.5.3. South Korea |
| 11.5.4. India |
| 11.5.5. Rest of APAC |
| 12. Latin America Collagen Wound Dressing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Source Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Natural |
| 12.1.1.1. Porcine |
| 12.1.1.2. Bovine |
| 12.1.1.3. Avian |
| 12.1.2. Synthetic |
| 12.1.2.1. Polymers |
| 12.1.2.2. Oxidized Regenerated Cellulose (ORC) |
| 12.1.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 12.2. Combination Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Antimicrobial |
| 12.2.2. Non-Antimicrobial |
| 12.3. Forms Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Gels |
| 12.3.2. Pastes |
| 12.3.3. Powders |
| 12.3.4. Others |
| 12.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Retail Pharmacy |
| 12.4.2. Online Pharmacy |
| 12.4.3. Hospitals |
| 12.4.4. Others |
| 12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1. Brazil |
| 12.5.2. Mexico |
| 12.5.3. Argentina |
| 12.5.4. Rest of Latin America |
| 13. MEA Collagen Wound Dressing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Source Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Natural |
| 13.1.1.1. Porcine |
| 13.1.1.2. Bovine |
| 13.1.1.3. Avian |
| 13.1.2. Synthetic |
| 13.1.2.1. Polymers |
| 13.1.2.2. Oxidized Regenerated Cellulose (ORC) |
| 13.1.2.3. Ethylene Diamine Tetraacetic Acid (EDTA) |
| 13.2. Combination Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Antimicrobial |
| 13.2.2. Non-Antimicrobial |
| 13.3. Forms Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Gels |
| 13.3.2. Pastes |
| 13.3.3. Powders |
| 13.3.4. Others |
| 13.4. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Retail Pharmacy |
| 13.4.2. Online Pharmacy |
| 13.4.3. Hospitals |
| 13.4.4. Others |
| 13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1. GCC Countries |
| 13.5.2. South Africa |
| 13.5.3. Rest of MEA |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. 3M Health Care Ltd. |
| 14.2.2. Acelity L.P. Inc. |
| 14.2.3. BSN medical GmbH |
| 14.2.4. Coloplast A/S |
| 14.2.5. ConvaTec Group plc |
| 14.2.6. Hollister Incorporated |
| 14.2.7. Integra LifeSciences Holdings Corporation |
| 14.2.8. Mölnlycke Health Care AB |
| 14.2.9. Smith & Nephew plc |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- 3M Health Care Ltd.
- Acelity L.P. Inc.
- BSN medical GmbH
- Coloplast A/S
- ConvaTec Group plc
- Hollister Incorporated
- Integra LifeSciences Holdings Corporation
- Mölnlycke Health Care AB
- Smith & Nephew plc